BDBM425933 US10512644, Compound 6-O-mPEG3-Nalbuphine

SMILES: COCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45

InChI Key: InChIKey=MXSQTNCHUNVXKA-VTSHJLIOSA-N

Data: 3 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 425933   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mu-type opioid receptor (Homo sapiens (Human))	BDBM425933 (US10512644, Compound 6-O-mPEG3-Nalbuphine) Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45 |r,TLB:13:14:35.18.17:27.29.28,THB:15:14:35.18.17:27.29.28| Show InChI InChI=1S/C28H41NO7/c1-32-11-12-33-13-14-34-15-16-35-22-7-8-28(31)23-17-20-5-6-21(30)25-24(20)27(28,26(22)36-25)9-10-29(23)18-19-3-2-4-19/h5-6,19,22-23,26,30-31H,2-4,7-18H2,1H3/t22-,23+,26-,27-,28+/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	27.4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inheris Pharmaceuticals, Inc. US Patent					Assay Description Briefly, the receptor binding affinity of the nalbuphine and PEG-nalbuphine conjugates was measured using radioligand binding assays in CHO cells tha...				US Patent US10512644 (2019) BindingDB Entry DOI: 10.7270/Q2RN3B8V
					More data for this Ligand-Target Pair
Delta-type opioid receptor (Homo sapiens (Human))	BDBM425933 (US10512644, Compound 6-O-mPEG3-Nalbuphine) Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45 |r,TLB:13:14:35.18.17:27.29.28,THB:15:14:35.18.17:27.29.28| Show InChI InChI=1S/C28H41NO7/c1-32-11-12-33-13-14-34-15-16-35-22-7-8-28(31)23-17-20-5-6-21(30)25-24(20)27(28,26(22)36-25)9-10-29(23)18-19-3-2-4-19/h5-6,19,22-23,26,30-31H,2-4,7-18H2,1H3/t22-,23+,26-,27-,28+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	163	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inheris Pharmaceuticals, Inc. US Patent					Assay Description Briefly, the receptor binding affinity of the nalbuphine and PEG-nalbuphine conjugates was measured using radioligand binding assays in CHO cells tha...				US Patent US10512644 (2019) BindingDB Entry DOI: 10.7270/Q2RN3B8V
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM425933 (US10512644, Compound 6-O-mPEG3-Nalbuphine) Show SMILES COCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45 |r,TLB:13:14:35.18.17:27.29.28,THB:15:14:35.18.17:27.29.28| Show InChI InChI=1S/C28H41NO7/c1-32-11-12-33-13-14-34-15-16-35-22-7-8-28(31)23-17-20-5-6-21(30)25-24(20)27(28,26(22)36-25)9-10-29(23)18-19-3-2-4-19/h5-6,19,22-23,26,30-31H,2-4,7-18H2,1H3/t22-,23+,26-,27-,28+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	218	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inheris Pharmaceuticals, Inc. US Patent					Assay Description Briefly, the receptor binding affinity of the nalbuphine and PEG-nalbuphine conjugates was measured using radioligand binding assays in CHO cells tha...				US Patent US10512644 (2019) BindingDB Entry DOI: 10.7270/Q2RN3B8V
					More data for this Ligand-Target Pair